C12N 2310/111
Spanning the whole gene, or a large part of it
Official title: spanning the whole gene, or a large part of it
C12N2310/111 (Spanning the whole gene, or a large part of it) appears on 1,084 US grants and 1,619 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,084
- Published applications
- 1,619
- Assignees
- 610
- Inventors
- 2,380
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 6 | 0 |
| 1993 | 8 | 0 |
| 1994 | 5 | 0 |
| 1995 | 10 | 0 |
| 1996 | 7 | 0 |
| 1997 | 44 | 0 |
| 1998 | 56 | 0 |
| 1999 | 68 | 0 |
| 2000 | 60 | 0 |
| 2001 | 37 | 9 |
| 2002 | 43 | 45 |
| 2003 | 28 | 108 |
| 2004 | 26 | 110 |
| 2005 | 7 | 172 |
| 2006 | 22 | 114 |
| 2007 | 22 | 92 |
| 2008 | 22 | 95 |
| 2009 | 28 | 147 |
| 2010 | 60 | 114 |
| 2011 | 68 | 106 |
| 2012 | 75 | 58 |
| 2013 | 64 | 65 |
| 2014 | 53 | 59 |
| 2015 | 62 | 63 |
| 2016 | 35 | 53 |
| 2017 | 32 | 46 |
| 2018 | 34 | 34 |
| 2019 | 26 | 37 |
| 2020 | 31 | 23 |
| 2021 | 11 | 10 |
| 2022 | 10 | 21 |
| 2023 | 8 | 13 |
| 2024 | 3 | 11 |
| 2025 | 4 | 7 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for inducing cell division of postmitotic cells23 Jun 2026US 12,661,384 B2The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone
- Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cells9 Jun 2026US 12,648,977 B2The University of North Carolina at Chapel Hill
- Anti-fibrotic compositions comprising FENDRR or fragments or variants thereof and methods of production and use thereof26 May 2026US 12,637,678 B2The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
- Modulation of prekallikrein (PKK) expression7 Apr 2026US 12,595,485 B2Ionis Pharmaceuticals, Inc.
- Anti-ADAM33 oligonucleotides and related methods10 Feb 2026US 12,545,915 B2University of Massachusetts
- Oligonucleotides for htt-1a modulation10 Sep 2026US 2026/0265747 A1University of Massachusetts
- Generation of neurons by reprogramming of oligodendrocytes and oligodendrocyte precursor cells3 Sep 2026US 2026/0256853 A1The University of North Carolina at Chapel Hill
- Long non-coding rna as therapeutic target in cardiac disorders and cardiac regeneration20 Aug 2026US 2026/0242872 A1Medizinische Hochschule Hannover
- Anti-adam33 oligonucleotides and related methods30 Jul 2026US 2026/0218196 A1University of Massachusetts
- Methods for treating monge's disease9 Jul 2026US 2026/0193659 A1The Regents of the University of California
Most cited
By later US patents
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- 2'deoxy-2'-alkylnucleotide containing nucleic acid521US 5,627,053 ARibozyme Pharmaceuticals, Inc. · 1997
- RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods496US 4,987,071 AUniversity Patents, Inc. · 1991
- Anti-sense regulation of gene expression in plant cells354US 5,107,065 ACalgene, Inc. · 1992
- Multivalent and multispecific binding proteins, their manufacture and use314US 5,837,242 ACambridge Antibody Technology Limited · 1998